Recombinant Protein Therapeutics and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Recombinant Protein Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Recombinant Protein Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Recombinant Protein Therapeutics Overall Market Size
2.1 Global Recombinant Protein Therapeutics Market Size: 2022 VS 2035
2.2 Global Recombinant Protein Therapeutics Market Size, Prospects & Forecasts: 2018-2035
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Recombinant Protein Therapeutics Players in Global Market
3.2 Top Global Recombinant Protein Therapeutics Companies Ranked by Revenue
3.3 Global Recombinant Protein Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Recombinant Protein Therapeutics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Recombinant Protein Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Recombinant Protein Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Recombinant Protein Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Recombinant Protein Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Recombinant Protein Therapeutics Market Size Markets, 2022 & 2035
4.1.2 Recombinant Hormones
4.1.3 Interferons
4.1.4 Interleukins
4.1.5 Hematopoietic Growth Factors
4.1.6 Others
4.2 By Type - Global Recombinant Protein Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Recombinant Protein Therapeutics Revenue, 2018-2023
4.2.2 By Type - Global Recombinant Protein Therapeutics Revenue, 2024-2035
4.2.3 By Type - Global Recombinant Protein Therapeutics Revenue Market Share, 2018-2035
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Recombinant Protein Therapeutics Market Size, 2022 & 2035
5.1.2 Diabetes
5.1.3 Dwarfism
5.1.4 Heart Disease
5.1.5 Cancer
5.1.6 Others
5.2 By Application - Global Recombinant Protein Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Recombinant Protein Therapeutics Revenue, 2018-2023
5.2.2 By Application - Global Recombinant Protein Therapeutics Revenue, 2024-2035
5.2.3 By Application - Global Recombinant Protein Therapeutics Revenue Market Share, 2018-2035
6 Sights by Region
6.1 By Region - Global Recombinant Protein Therapeutics Market Size, 2022 & 2035
6.2 By Region - Global Recombinant Protein Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Recombinant Protein Therapeutics Revenue, 2018-2023
6.2.2 By Region - Global Recombinant Protein Therapeutics Revenue, 2024-2035
6.2.3 By Region - Global Recombinant Protein Therapeutics Revenue Market Share, 2018-2035
6.3 North America
6.3.1 By Country - North America Recombinant Protein Therapeutics Revenue, 2018-2035
6.3.2 US Recombinant Protein Therapeutics Market Size, 2018-2035
6.3.3 Canada Recombinant Protein Therapeutics Market Size, 2018-2035
6.3.4 Mexico Recombinant Protein Therapeutics Market Size, 2018-2035
6.4 Europe
6.4.1 By Country - Europe Recombinant Protein Therapeutics Revenue, 2018-2035
6.4.2 Germany Recombinant Protein Therapeutics Market Size, 2018-2035
6.4.3 France Recombinant Protein Therapeutics Market Size, 2018-2035
6.4.4 U.K. Recombinant Protein Therapeutics Market Size, 2018-2035
6.4.5 Italy Recombinant Protein Therapeutics Market Size, 2018-2035
6.4.6 Russia Recombinant Protein Therapeutics Market Size, 2018-2035
6.4.7 Nordic Countries Recombinant Protein Therapeutics Market Size, 2018-2035
6.4.8 Benelux Recombinant Protein Therapeutics Market Size, 2018-2035
6.5 Asia
6.5.1 By Region - Asia Recombinant Protein Therapeutics Revenue, 2018-2035
6.5.2 China Recombinant Protein Therapeutics Market Size, 2018-2035
6.5.3 Japan Recombinant Protein Therapeutics Market Size, 2018-2035
6.5.4 South Korea Recombinant Protein Therapeutics Market Size, 2018-2035
6.5.5 Southeast Asia Recombinant Protein Therapeutics Market Size, 2018-2035
6.5.6 India Recombinant Protein Therapeutics Market Size, 2018-2035
6.6 South America
6.6.1 By Country - South America Recombinant Protein Therapeutics Revenue, 2018-2035
6.6.2 Brazil Recombinant Protein Therapeutics Market Size, 2018-2035
6.6.3 Argentina Recombinant Protein Therapeutics Market Size, 2018-2035
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Recombinant Protein Therapeutics Revenue, 2018-2035
6.7.2 Turkey Recombinant Protein Therapeutics Market Size, 2018-2035
6.7.3 Israel Recombinant Protein Therapeutics Market Size, 2018-2035
6.7.4 Saudi Arabia Recombinant Protein Therapeutics Market Size, 2018-2035
6.7.5 UAE Recombinant Protein Therapeutics Market Size, 2018-2035
7 Recombinant Protein Therapeutics Companies Profiles
7.1 Eli Lilly
7.1.1 Eli Lilly Company Summary
7.1.2 Eli Lilly Business Overview
7.1.3 Eli Lilly Recombinant Protein Therapeutics Major Product Offerings
7.1.4 Eli Lilly Recombinant Protein Therapeutics Revenue in Global Market (2018-2023)
7.1.5 Eli Lilly Key News & Latest Developments
7.2 Pfizer
7.2.1 Pfizer Company Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Recombinant Protein Therapeutics Major Product Offerings
7.2.4 Pfizer Recombinant Protein Therapeutics Revenue in Global Market (2018-2023)
7.2.5 Pfizer Key News & Latest Developments
7.3 Merck
7.3.1 Merck Company Summary
7.3.2 Merck Business Overview
7.3.3 Merck Recombinant Protein Therapeutics Major Product Offerings
7.3.4 Merck Recombinant Protein Therapeutics Revenue in Global Market (2018-2023)
7.3.5 Merck Key News & Latest Developments
7.4 Roche
7.4.1 Roche Company Summary
7.4.2 Roche Business Overview
7.4.3 Roche Recombinant Protein Therapeutics Major Product Offerings
7.4.4 Roche Recombinant Protein Therapeutics Revenue in Global Market (2018-2023)
7.4.5 Roche Key News & Latest Developments
7.5 Biogen
7.5.1 Biogen Company Summary
7.5.2 Biogen Business Overview
7.5.3 Biogen Recombinant Protein Therapeutics Major Product Offerings
7.5.4 Biogen Recombinant Protein Therapeutics Revenue in Global Market (2018-2023)
7.5.5 Biogen Key News & Latest Developments
7.6 Bayer
7.6.1 Bayer Company Summary
7.6.2 Bayer Business Overview
7.6.3 Bayer Recombinant Protein Therapeutics Major Product Offerings
7.6.4 Bayer Recombinant Protein Therapeutics Revenue in Global Market (2018-2023)
7.6.5 Bayer Key News & Latest Developments
7.7 J&J
7.7.1 J&J Company Summary
7.7.2 J&J Business Overview
7.7.3 J&J Recombinant Protein Therapeutics Major Product Offerings
7.7.4 J&J Recombinant Protein Therapeutics Revenue in Global Market (2018-2023)
7.7.5 J&J Key News & Latest Developments
7.8 Amgen
7.8.1 Amgen Company Summary
7.8.2 Amgen Business Overview
7.8.3 Amgen Recombinant Protein Therapeutics Major Product Offerings
7.8.4 Amgen Recombinant Protein Therapeutics Revenue in Global Market (2018-2023)
7.8.5 Amgen Key News & Latest Developments
7.9 Sanofi
7.9.1 Sanofi Company Summary
7.9.2 Sanofi Business Overview
7.9.3 Sanofi Recombinant Protein Therapeutics Major Product Offerings
7.9.4 Sanofi Recombinant Protein Therapeutics Revenue in Global Market (2018-2023)
7.9.5 Sanofi Key News & Latest Developments
7.10 Ligand
7.10.1 Ligand Company Summary
7.10.2 Ligand Business Overview
7.10.3 Ligand Recombinant Protein Therapeutics Major Product Offerings
7.10.4 Ligand Recombinant Protein Therapeutics Revenue in Global Market (2018-2023)
7.10.5 Ligand Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Recombinant Protein Therapeutics Market Opportunities & Trends in Global Market
Table 2. Recombinant Protein Therapeutics Market Drivers in Global Market
Table 3. Recombinant Protein Therapeutics Market Restraints in Global Market
Table 4. Key Players of Recombinant Protein Therapeutics in Global Market
Table 5. Top Recombinant Protein Therapeutics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Recombinant Protein Therapeutics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Recombinant Protein Therapeutics Revenue Share by Companies, 2018-2023
Table 8. Global Companies Recombinant Protein Therapeutics Product Type
Table 9. List of Global Tier 1 Recombinant Protein Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Recombinant Protein Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Recombinant Protein Therapeutics Revenue, (US$, Mn), 2022 & 2035
Table 12. By Type - Recombinant Protein Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Recombinant Protein Therapeutics Revenue in Global (US$, Mn), 2024-2035
Table 14. By Application ? Global Recombinant Protein Therapeutics Revenue, (US$, Mn), 2022 & 2035
Table 15. By Application - Recombinant Protein Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Recombinant Protein Therapeutics Revenue in Global (US$, Mn), 2024-2035
Table 17. By Region ? Global Recombinant Protein Therapeutics Revenue, (US$, Mn), 2022 & 2035
Table 18. By Region - Global Recombinant Protein Therapeutics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Recombinant Protein Therapeutics Revenue (US$, Mn), 2024-2035
Table 20. By Country - North America Recombinant Protein Therapeutics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Recombinant Protein Therapeutics Revenue, (US$, Mn), 2024-2035
Table 22. By Country - Europe Recombinant Protein Therapeutics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Recombinant Protein Therapeutics Revenue, (US$, Mn), 2024-2035
Table 24. By Region - Asia Recombinant Protein Therapeutics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Recombinant Protein Therapeutics Revenue, (US$, Mn), 2024-2035
Table 26. By Country - South America Recombinant Protein Therapeutics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Recombinant Protein Therapeutics Revenue, (US$, Mn), 2024-2035
Table 28. By Country - Middle East & Africa Recombinant Protein Therapeutics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Recombinant Protein Therapeutics Revenue, (US$, Mn), 2024-2035
Table 30. Eli Lilly Company Summary
Table 31. Eli Lilly Recombinant Protein Therapeutics Product Offerings
Table 32. Eli Lilly Recombinant Protein Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 33. Eli Lilly Key News & Latest Developments
Table 34. Pfizer Company Summary
Table 35. Pfizer Recombinant Protein Therapeutics Product Offerings
Table 36. Pfizer Recombinant Protein Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 37. Pfizer Key News & Latest Developments
Table 38. Merck Company Summary
Table 39. Merck Recombinant Protein Therapeutics Product Offerings
Table 40. Merck Recombinant Protein Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 41. Merck Key News & Latest Developments
Table 42. Roche Company Summary
Table 43. Roche Recombinant Protein Therapeutics Product Offerings
Table 44. Roche Recombinant Protein Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 45. Roche Key News & Latest Developments
Table 46. Biogen Company Summary
Table 47. Biogen Recombinant Protein Therapeutics Product Offerings
Table 48. Biogen Recombinant Protein Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 49. Biogen Key News & Latest Developments
Table 50. Bayer Company Summary
Table 51. Bayer Recombinant Protein Therapeutics Product Offerings
Table 52. Bayer Recombinant Protein Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 53. Bayer Key News & Latest Developments
Table 54. J&J Company Summary
Table 55. J&J Recombinant Protein Therapeutics Product Offerings
Table 56. J&J Recombinant Protein Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 57. J&J Key News & Latest Developments
Table 58. Amgen Company Summary
Table 59. Amgen Recombinant Protein Therapeutics Product Offerings
Table 60. Amgen Recombinant Protein Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 61. Amgen Key News & Latest Developments
Table 62. Sanofi Company Summary
Table 63. Sanofi Recombinant Protein Therapeutics Product Offerings
Table 64. Sanofi Recombinant Protein Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 65. Sanofi Key News & Latest Developments
Table 66. Ligand Company Summary
Table 67. Ligand Recombinant Protein Therapeutics Product Offerings
Table 68. Ligand Recombinant Protein Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 69. Ligand Key News & Latest Developments
List of Figures
Figure 1. Recombinant Protein Therapeutics Segment by Type in 2022
Figure 2. Recombinant Protein Therapeutics Segment by Application in 2022
Figure 3. Global Recombinant Protein Therapeutics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Recombinant Protein Therapeutics Market Size: 2022 VS 2035 (US$, Mn)
Figure 6. Global Recombinant Protein Therapeutics Revenue, 2018-2035 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Recombinant Protein Therapeutics Revenue in 2022
Figure 8. By Type - Global Recombinant Protein Therapeutics Revenue Market Share, 2018-2035
Figure 9. By Application - Global Recombinant Protein Therapeutics Revenue Market Share, 2018-2035
Figure 10. By Type - Global Recombinant Protein Therapeutics Revenue, (US$, Mn), 2022 & 2035
Figure 11. By Type - Global Recombinant Protein Therapeutics Revenue Market Share, 2018-2035
Figure 12. By Application - Global Recombinant Protein Therapeutics Revenue, (US$, Mn), 2022 & 2035
Figure 13. By Application - Global Recombinant Protein Therapeutics Revenue Market Share, 2018-2035
Figure 14. By Region - Global Recombinant Protein Therapeutics Revenue Market Share, 2018-2035
Figure 15. By Country - North America Recombinant Protein Therapeutics Revenue Market Share, 2018-2035
Figure 16. US Recombinant Protein Therapeutics Revenue, (US$, Mn), 2018-2035
Figure 17. Canada Recombinant Protein Therapeutics Revenue, (US$, Mn), 2018-2035
Figure 18. Mexico Recombinant Protein Therapeutics Revenue, (US$, Mn), 2018-2035
Figure 19. By Country - Europe Recombinant Protein Therapeutics Revenue Market Share, 2018-2035
Figure 20. Germany Recombinant Protein Therapeutics Revenue, (US$, Mn), 2018-2035
Figure 21. France Recombinant Protein Therapeutics Revenue, (US$, Mn), 2018-2035
Figure 22. U.K. Recombinant Protein Therapeutics Revenue, (US$, Mn), 2018-2035
Figure 23. Italy Recombinant Protein Therapeutics Revenue, (US$, Mn), 2018-2035
Figure 24. Russia Recombinant Protein Therapeutics Revenue, (US$, Mn), 2018-2035
Figure 25. Nordic Countries Recombinant Protein Therapeutics Revenue, (US$, Mn), 2018-2035
Figure 26. Benelux Recombinant Protein Therapeutics Revenue, (US$, Mn), 2018-2035
Figure 27. By Region - Asia Recombinant Protein Therapeutics Revenue Market Share, 2018-2035
Figure 28. China Recombinant Protein Therapeutics Revenue, (US$, Mn), 2018-2035
Figure 29. Japan Recombinant Protein Therapeutics Revenue, (US$, Mn), 2018-2035
Figure 30. South Korea Recombinant Protein Therapeutics Revenue, (US$, Mn), 2018-2035
Figure 31. Southeast Asia Recombinant Protein Therapeutics Revenue, (US$, Mn), 2018-2035
Figure 32. India Recombinant Protein Therapeutics Revenue, (US$, Mn), 2018-2035
Figure 33. By Country - South America Recombinant Protein Therapeutics Revenue Market Share, 2018-2035
Figure 34. Brazil Recombinant Protein Therapeutics Revenue, (US$, Mn), 2018-2035
Figure 35. Argentina Recombinant Protein Therapeutics Revenue, (US$, Mn), 2018-2035
Figure 36. By Country - Middle East & Africa Recombinant Protein Therapeutics Revenue Market Share, 2018-2035
Figure 37. Turkey Recombinant Protein Therapeutics Revenue, (US$, Mn), 2018-2035
Figure 38. Israel Recombinant Protein Therapeutics Revenue, (US$, Mn), 2018-2035
Figure 39. Saudi Arabia Recombinant Protein Therapeutics Revenue, (US$, Mn), 2018-2035
Figure 40. UAE Recombinant Protein Therapeutics Revenue, (US$, Mn), 2018-2035
Figure 41. Eli Lilly Recombinant Protein Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Pfizer Recombinant Protein Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Merck Recombinant Protein Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Roche Recombinant Protein Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Biogen Recombinant Protein Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Bayer Recombinant Protein Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. J&J Recombinant Protein Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Amgen Recombinant Protein Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Sanofi Recombinant Protein Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Ligand Recombinant Protein Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Industry Market Size
